Quantum Biosciences
Quantum Biosciences builds tools that enable earlier cancer detection and personalized treatment through quantum-enabled bioscience. Its core platforms include ultra-sensitive NV diamond quantum sensors for real-time cellular stress detection, Gemini AI-driven digital twin for virtual patient models to optimize therapy, and exosome-based biomarker discovery for ovarian cancer. The company combines quantum physics, AI, and bioscience, targeting researchers, clinicians, and industry partners. It operates on a research and development and partnership model, collaborating with academic and industry players. Headquartered in Santa Clara and Bangalore, it aims to scale precision medicine through data-driven platforms.
Quantum Biosciences
Quantum Biosciences builds tools that enable earlier cancer detection and personalized treatment through quantum-enabled bioscience. Its core platforms include ultra-sensitive NV diamond quantum sensors for real-time cellular stress detection, Gemini AI-driven digital twin for virtual patient models to optimize therapy, and exosome-based biomarker discovery for ovarian cancer. The company combines quantum physics, AI, and bioscience, targeting researchers, clinicians, and industry partners. It operates on a research and development and partnership model, collaborating with academic and industry players. Headquartered in Santa Clara and Bangalore, it aims to scale precision medicine through data-driven platforms.